Asymchem Laboratories (Tianjin) Co., Ltd.

SZSE:002821 Rapporto sulle azioni

Cap. di mercato: CN¥29.4b

Asymchem Laboratories (Tianjin) Crescita futura

Future criteri di controllo 4/6

Asymchem Laboratories (Tianjin) prevede che gli utili e i ricavi cresceranno rispettivamente di 29.9% e 18.3% all'anno. Si prevede che l'EPS crescerà di 29.8% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 8.8% in 3 anni.

Informazioni chiave

29.9%

Tasso di crescita degli utili

29.8%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili19.3%
Tasso di crescita dei ricavi18.3%
Rendimento futuro del capitale proprio8.8%
Copertura analitica

Good

Ultimo aggiornamento18 Nov 2024

Aggiornamenti recenti sulla crescita futura

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Apr 03
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Recent updates

Earnings Troubles May Signal Larger Issues for Asymchem Laboratories (Tianjin) (SZSE:002821) Shareholders

Nov 05
Earnings Troubles May Signal Larger Issues for Asymchem Laboratories (Tianjin) (SZSE:002821) Shareholders

Estimating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Oct 15
Estimating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Investors Still Aren't Entirely Convinced By Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings Despite 25% Price Jump

Sep 28
Investors Still Aren't Entirely Convinced By Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings Despite 25% Price Jump

Is There An Opportunity With Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) 49% Undervaluation?

Jul 16
Is There An Opportunity With Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) 49% Undervaluation?

Asymchem Laboratories (Tianjin) (SZSE:002821) Is Paying Out A Dividend Of CN¥1.80

Jun 27
Asymchem Laboratories (Tianjin) (SZSE:002821) Is Paying Out A Dividend Of CN¥1.80

Benign Growth For Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Underpins Its Share Price

Jun 26
Benign Growth For Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Underpins Its Share Price

Does Asymchem Laboratories (Tianjin) (SZSE:002821) Have A Healthy Balance Sheet?

May 22
Does Asymchem Laboratories (Tianjin) (SZSE:002821) Have A Healthy Balance Sheet?

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Apr 03
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Downgrade: Here's How Analysts See Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Performing In The Near Term

Apr 02
Downgrade: Here's How Analysts See Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Performing In The Near Term

A Look At The Fair Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Mar 26
A Look At The Fair Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 04
Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Previsioni di crescita degli utili e dei ricavi

SZSE:002821 - Stime future degli analisti e dati finanziari passati (CNY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20268,6661,7969072,14614
12/31/20257,2461,5087361,48615
12/31/20245,9101,0701,1821,67910
9/30/20245,5717694271,738N/A
6/30/20245,9011,0828052,170N/A
3/31/20246,9761,9201,4812,737N/A
12/31/20237,8252,2692,3083,550N/A
9/30/20238,8012,7911,9583,312N/A
6/30/20239,8363,2483,2444,908N/A
3/31/202310,4453,4332,5434,386N/A
1/1/202310,2553,3021,1363,287N/A
9/30/20229,5083,0944522,606N/A
6/30/20227,9182,382-1,834267N/A
3/31/20225,9151,413-1,832217N/A
12/31/20214,6321,068-1,547113N/A
9/30/20213,977908-986572N/A
6/30/20213,626830-391916N/A
3/31/20213,438766-514624N/A
12/31/20203,137719-442573N/A
9/30/20202,800694-72596N/A
6/30/20202,63364051582N/A
3/31/20202,45957092574N/A
12/31/20192,46055490601N/A
9/30/20192,372534-61493N/A
6/30/20192,170501-236309N/A
3/31/20191,948457-222351N/A
12/31/20181,835428-128415N/A
9/30/20181,732401-287223N/A
6/30/20181,629373N/A306N/A
3/31/20181,497356N/A181N/A
12/31/20171,423341N/A196N/A
9/30/20171,213265N/A277N/A
6/30/20171,184289N/A338N/A
3/31/20171,207269N/A372N/A
12/31/20161,103253N/A278N/A
9/30/20161,097260N/A285N/A
12/31/2015831154N/A257N/A
12/31/2014716102N/A127N/A
12/31/201354375N/A106N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 002821 ( 29.9% all'anno) è superiore al tasso di risparmio ( 2.8% ).

Guadagni vs Mercato: Si prevede che gli utili di 002821 ( 29.9% all'anno) cresceranno più rapidamente del mercato CN ( 26% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 002821 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di 002821 ( 18.3% all'anno) crescerà più rapidamente del mercato CN ( 13.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 002821 ( 18.3% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 002821 sarà basso tra 3 anni ( 8.8 %).


Scoprire le aziende in crescita